A stratification system for evaluating and selecting therapies in patients with relapsed or primary refractory acute myelogenous leukemia [letter]

Estey, E; Kornblau, S; Pierce, S; Kantarjian, H; Beran, M; Keating, M

doi:10.1182/blood.V88.2.756.bloodjournal882756

E Estey,

E Estey

Search for other works by this author on:

This Site

PubMed

Google Scholar

S Kornblau,

S Kornblau

Search for other works by this author on:

This Site

PubMed

Google Scholar

S Pierce,

S Pierce

Search for other works by this author on:

This Site

PubMed

Google Scholar

H Kantarjian,

H Kantarjian

Search for other works by this author on:

This Site

PubMed

Google Scholar

M Beran,

M Beran

Search for other works by this author on:

This Site

PubMed

Google Scholar

M Keating

Search for other works by this author on:

This Site

PubMed

Google Scholar

A stratification system for evaluating and selecting therapies in patients with relapsed or primary refractory acute myelogenous leukemia [letter]

Article PDF first page preview

Contents

Data & Figures

Supplemental data

References

Cited By

Email alerts

ASH Publications

American Society of Hematology

A stratification system for evaluating and selecting therapies in patients with relapsed or primary refractory acute myelogenous leukemia [letter]

Article PDF first page preview

Contents

Data & Figures

Supplemental data

References

Related

Related

Cited By

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only